Qinecsa Highlights - October 2024
Latest News
Welcoming Adam Sherlock as Qinecsa's New CEO.
On October 8th, we were delighted to announce that one of the life science industry’s most respected and experienced CEOs, Adam Sherlock , has joined us as CEO.
Veteran safety & pharmacovigilance leader Adam Sherlock will capitalize on Qinecsa's deep domain expertise and comprehensive technology-powered solutions to pharma’s most complex product safety challenges.
We look forward to the exciting developments ahead under Adam's leadership.
Welcome to the Qinecsa Team, Adam!
Industry News
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) Meeting, 28-31 October 2024
In this meeting, the committee did not initiate or conclude any referral procedures. All ongoing safety reviews are available in the ‘Ongoing referrals’ table, including new signals detected from EU spontaneous reporting systems and more. Information on all topics discussed by the PRAC are available in their agenda.
Past Events
Conference | 09 - 10 October 2024 | Amsterdam, NL
Round-Up of the World Drug Safety Congress Europe 2024!
What an exciting time it was on the buzzing exhibition floor at World Drug Safety Congress EU in Amsterdam. The event was filled with engaging discussions and strong interest in our Reportum Unified Intake platform live demo as well as in all our full suite of services supporting the full end-to-end requirement of the pharmacovigilance process for all size clients.
Special thanks to?Martin Holm-Petersen,?Qinecsa CSO and CEO of Insife, a Qinecsa company, for delivering two insightful presentations:?“Future-proofing pharmacovigilance: governance, data collection, and analyses for global success” and “The Roadmap for PV Innovation: Technology-led Advancements from Now to 2030.”
?Heartfelt thanks to everyone who helped make this event such a success!
Conference | 29-30 October? 2024?| Boston, MA USA
Last Week’s World Drug Safety Congress Americas Recap: Engaging, Innovating, Leading!?
Our booth drew strong engagement among attendees with many productive meetings, affirming that we’re moving in the right direction in solidifying Qinecsa as the leading solution provider in drug safety.
We were pleased to have?Martin Holm-Petersen,?Qinecsa CSO and CEO of Insife, a Qinecsa company, deliver an inspirational presentation, and seeing?Daniel O'keeffe,?Qinecsa VP of Product - Reportum, bring energy to the floor with a passionate live interview.
Thank you to everyone who visited us and took the time to connect with us!
?Enjoy a glimpse behind the scenes below.
Hot Topic ?
??Reminder This week 4-10 November is #MedSafetyWeek!
At Qinecsa, we’re committed to supporting the global movement to enhance patient safety.?
Each year, regulatory authorities and national pharmacovigilance centers across the world team up to run a social media campaign that raises awareness of adverse drug reactions.
Join us and help spread the word on the importance of preventing and reporting side effects, as research indicates that nearly half of all side effects are preventable.
?? Special thanks to the Uppsala Monitoring Centre (UMC) for their continuous efforts in raising awareness of this vital message worldwide. ??
We look forward to keeping you informed and engaged!
Warm regards,
The Qinecsa Team
Qinecsa - Global specialists in technology-led end-to-end pharmacovigilance solutions!
We’d love to hear from you! Share your thoughts and feedback at [email protected]